Bloomberg
Sanofi's CFO Says Growth in EM Has Been Steady
Jul.31 -- Jerome Contamine, chief financial officer at Sanofi, discusses quarterly earnings, growth in emerging markets, the winding down of older drugs, his outlook for new drugs and his outlook for M&A. He speaks on "Bloomberg Markets:...
Bloomberg
J&J CFO Says Stronger Dollar Hurt Profit Outlook
Jan.24 -- Dominic Caruso, chief financial officer at Johnson & Johnson, discusses fourth-quarter results and the company's outlook for 2017. He speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas."
Bloomberg
Novartis CEO Says Trump Discussed Pricing With Drug CEOs
Apr.18 -- Joseph Jimenez, chief executive officer at Novartis, discusses talks with President Trump including performance based pricing. He speaks with Francine Lacqua on "Bloomberg Surveillance."
Bloomberg
Coronavirus Treatment: Antibodies and the Race for a Vaccine
May.04 -- Takeda President of Global Business Rajeev Venkayya discusses efforts among companies and nations to develop a coronavirus vaccine and the importance of making the vaccine available to the entire world. He speaks on "Bloomberg...
Bloomberg
Kotak Mahindra Bank MD: Now’s Best Time to Invest in India
Oct.16 -- Uday Kotak, the managing director of Kotak Mahindra Bank Ltd., explains why he thinks overseas investors should look to invest in Indian digital to consumer sector companies. Kotak, Asia’s richest banker, spoke Thursday with...
Bloomberg
Are Chinese Health-Care Stocks Going to Rise Further in 2020?
Jan.07 -- Jay Lee, equity analyst at Morningstar, talks about Chinese health-care stocks. He speaks with David Ingles, Yvonne Man and Tom Mackenzie on "Bloomberg Markets: China Open."
Bloomberg
TSX Movers: Redknee Solutions, Precision Drilling
June 1 -- Redknee Solutions soars after renewing a multi-million dollar services contract, Precision Drilling falls after Credit Suite downgrades the stock, and Valeant Pharmaceuticals has a date set for a 1Q results conference call. ...
Bloomberg
Kamada Remains Focused on Lung Treatment: CEO Tsur
Oct. 23 -- David Tsur, chief executive officer at Kamada, talks with Elliott Gotkine about what comes next for the company after a failed trial for an inhaled treatment for AAT. He speaks on The Pulse.
Bloomberg
The Biggest Hurdles Facing Obamacare
Nov. 17 -- PricewaterhouseCoopers Health Research Institute's Ceci Connolly discusses the new health economy and the hurdles facing Obamacare with Bloomberg's Mark Crumpton on ""Bottom Line."" (Source: Bloomberg)
Bloomberg
CVS Is Said to Be in Talks to Buy Aetna: WSJ
Oct.26 -- Aetna Inc. gained in New York trading after the Wall Street Journal reported that CVS Health Corp. is in talks to buy the insurer, offering more than $200 a share. Bloomberg Intelligence's Jason McGorman has more on "What'd You...
Bloomberg
Gilead to Buy Kite for $11.9 Billion in Cancer Megadeal
Aug.28 -- Bloomberg’s Taylor Riggs discusses a Gilead Sciences-Kite Pharma deal. She speaks with Bloomberg's Vonnie Quinn on "Bloomberg Markets."
Bloomberg
Distribution Is Key for Amazon on Health Care, Says UBS's Forbes
Feb.26 -- Jim Forbes, vice chairman at UBS Investment Bank, and Bloomberg's Drew Armstrong discuss health care disruption and consolidation. They speak on "Bloomberg Daybreak: Americas."
Bloomberg
Trudeau Says Canada Is Legalizing Pot to Protect Kids
Apr.20 -- Canadian Prime Minister Justin Trudeau comments on Canada's approach to the legalization of marijuana. He speaks during an interview with Bloomberg Editor-in-Chief John Micklethwait.
Bloomberg
Fauci Is 'Cautiously Optimistic' a Covid-19 Vaccine Will Be Found
Apr.28 -- Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, says he's hopeful a vaccine for Covid-19 will be found by the winter. He speaks to David Rubenstein, host of "Peer-to-Peer...
Bloomberg
India May Gain Access to Covid Vaccine Early 2021: Analyst
Sep.04 -- Nithya Balasubramanian, healthcare analyst for India at Bernstein, explains why she expects an approved vaccine to be in the market in early 2021, and the outlook for the country's pharmaceutical industry. She speaks with...
Bloomberg
Split Personality: How a Divided Congress May Hit Banks, Tech & Pharma
Nov.05 -- With a divided U.S. Congress, analysts think bank and pharmaceutical stocks could come out relatively unharmed, or even supported, if Democrats cause gridlock with Donald Trump's agenda. But the pain could continue for tech and...
Bloomberg
J&J Tops 3Q Estimates, Boosts Full-Year Profit Guidance
Oct.16 -- Joseph Wolk, chief financial officer at Johnson & Johnson, discusses third-quarter results and the factors behind a boost to full-year guidance. He speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas."
Bloomberg
Deals Report: Eldorado-Caesars Merger, Bristol-Myers to Divest Celgene Drug
Jun.24 -- Bloomberg's Ed Hammond takes a look at the latest deals in M&A. He speaks on "Bloomberg Markets: The Close."
Bloomberg
J&J Raises Sales Forecast on Pharmaceutical Growth
Jul.16 -- Joe Wolk, chief financial officer at Johnson & Johnson, discusses second-quarter results, the company’s acquisition plans, and potential liabilities from talc lawsuits. He speaks with Bloomberg's David Westin on "Bloomberg...
Bloomberg
Moderna Chair Says Covid Pandemic May Shift to Endemic in 2022
Moderna Inc. co-founder Noubar Afeyan says the Covid-19 pandemic could start moving into an endemic phase in 2022. "It really depends on what happens and the decisions that are made across the world," Afeyan said on Bloomberg Television,...
AFP News Agency
VOICED : Nobel Chemistry Prize: a "cheaper, simpler" and greener way to make chemicals (expert)
Member of the Chemistry Nobel committee Pernilla Wittung-Stafhede talks about this year's award, given to Benjamin List and David MacMillan for discovering a new technique to create chemicals (Footage by AFPTV via Getty Images)
Bloomberg
No Activity on an Ebola Vaccine: Collplant Founder
Nov. 6 -- Oded Shoseyov, founder and chief scientific officer at Collplant Holdings, talks with Elliott Gotkine about the companys process to produce plant-based human collagen, the new products coming to market and the possibility of...
Bloomberg
Sanofi 3Q EPS EU1.47; Est. EU1.46
Oct. 28 ""French drug maker Sanofi reports earnings for the third quarter. Bloomberg's Mark Barton reports on ""Countdown. (Source: Bloomberg)
Bloomberg
Drug, Device Companies Paid U.S. Doctors $3.5B Last Year
Sept. 30 -- U.S. doctors and teaching hospitals were paid $3.5 billion by drug and device makers over five months in 2013, according to the first comprehensive disclosure of the companies financial ties to the medical professionals that...